https://orcid.org/0000-0002-9996-8788
References
- Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;50 Suppl 1:1–6. doi:10.1086/647939.
- de Bleecker JL, Leroy BP, Meire VI. Reversible visual deficit and corpus callosum lesions due to metronidazole toxicity. Eur Neurol. 2005;53(2):93–95. doi:10.1159/000085506.
- McGrath NM, Kent-Smith B, Sharp DM. Reversible optic neuropathy due to metronidazole. Clin Exp Ophthalmol. 2007;35(6):585–586. doi:10.1111/j.1442-9071.2007.01537.x.
- Anwyll N, Gerry P, Gormley J. Reversible optic neuropathy secondary to metronidazole. BMJ Case Rep. 2020;13(12):e237141. doi:10.1136/bcr-2020-237141.
- Peng PH, Wu TE, Lin TY. Metronidazole-Induced irreversible optic neuropathy. Case Rep Ophthalmol. 2021;12(2):392–395. doi:10.1159/000512625.
- Nuro E, Bursztyn LL, Mendonça DA, et al. Neuroimaging evidence of optic tract involvement in metronidazole-induced optic neuropathy. Can J Neurol Sci. 2023;50(2):290–291.
- Putnam D, Fraunfelder FT, Dreis M. Metronidazole and optic neuritis. Am J Ophthalmol. 1991;112(6):737. doi:10.1016/s0002-9394(14)77290-3.
- Rosenblatt JE, Edson RS. Metronidazole. Mayo Clin Proc. 1983;58(3):154–157.
- Edwards DI. Nitroimidazole drugs–action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother. 1993;31(1):9–20. doi:10.1093/jac/31.1.9.
- Hernández Ceruelos A, Romero-Quezada LC, Ruvalcaba Ledezma JC, et al. Therapeutic uses of metronidazole and its side effects: an update. Eur Rev Med Pharmacol Sci. 2019;23(1):397–401.
- Rao DN, Mason RP. Generation of nitro radical anions of some 5-nitrofurans, 2- and 5-nitroimidazoles by norepinephrine, dopamine, and serotonin. A possible mechanism for neurotoxicity caused by nitroheterocyclic drugs. J Biol Chem. 1987;262(24):11731–11736.
- Alston TA, Abeles RH. Enzymatic conversion of the antibiotic metronidazole to an analog of thiamine. Arch Biochem Biophys. 1987;257(2):357–362.
- Hassan MH, Awadalla EA, Ali RA, et al. Thiamine deficiency and oxidative stress induced by prolonged metronidazole therapy can explain its side effects of neurotoxicity and infertility in experimental animals: effect of grapefruit co-therapy. Hum Exp Toxicol. 2020;39(6):834–847. doi:10.1177/0960327119867755.
- Bradley WG, Karlsson IJ, Rassol CG. Metronidazole neuropathy. Br Med J. 1977;2(6087):610–611.
- Gal RL, Vedula SS, Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev. 2015;2015(8):Cd001430.
- Beck RW, Cleary PA, Anderson MM, Jr., et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The optic neuritis study group. N Engl J Med. 1992;326(9):581–588. doi:10.1056/NEJM199202273260901.
- Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The optic neuritis study group. N Engl J Med. 1993;329(24):1764–1769. doi:10.1056/NEJM199312093292403.
- Noseworthy JH, O’Brien PC, Petterson TM, et al. A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology. 2001;56(11):1514–1522. doi:10.1212/wnl.56.11.1514.
- Roed HG, Langkilde A, Sellebjerg F, et al. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis. Neurology. 2005;64(5):804–810. doi:10.1212/01.WNL.0000152873.82631.B3.
- Ruprecht K, Klinker E, Dintelmann T, et al. Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology. 2004;63(6):1081–1083. doi:10.1212/01.wnl.0000138437.99046.6b.
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. doi:10.1038/clpt.1981.154.